Related Experiment Videos
Bayesian adaptive biased-coin designs for clinical trials with normal responses
Anthony C Atkinson1, Atanu Biswas
1Department of Statistics, London School of Economics, London WC2A 2AE, UK. A.C.Atkinson@lse.ac.uk
Biometrics
|March 2, 2005
Summary
Adaptive clinical trial designs use a skewed Bayesian biased-coin procedure to allocate more patients to superior treatments. This method optimizes sequential trials for continuous responses, improving treatment selection efficiency.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Experimental Design
Background:
- Adaptive designs enhance clinical trial efficiency by modifying trial parameters during the study.
- Phase III clinical trials aim to identify superior treatments, necessitating effective allocation strategies.
Purpose of the Study:
- To develop a skewed Bayesian biased-coin procedure for adaptive sequential clinical trials.
- To evaluate the performance of these skewed designs for continuous response variables.
Main Methods:
- Utilized optimum design theory to derive the skewed Bayesian biased-coin procedure.
- Employed numerical and theoretical analyses to study the performance of the adaptive designs.
- Focused on key performance properties such as treatment allocation proportion and associated loss.
Main Results:
- The derived skewed designs demonstrated adaptive capabilities in sequential trials.
- Performance analysis indicated favorable allocation patterns towards more effective treatments.
- Quantified the trade-offs between treatment allocation and potential loss.
Conclusions:
- The proposed skewed Bayesian biased-coin procedure offers an effective adaptive design for phase III clinical trials.
- These designs can improve the efficiency of identifying and allocating patients to superior treatments.
- The methodology provides a robust framework for optimizing sequential trial designs with continuous outcomes.